KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Revenue: 2014-2024

Historic Revenue for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $3.8 billion.

  • BeOne Medicines' Revenue rose 41.00% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 49.92%. This contributed to the annual value of $3.8 billion for FY2024, which is 54.96% up from last year.
  • Per BeOne Medicines' latest filing, its Revenue stood at $3.8 billion for FY2024, which was up 54.96% from $2.5 billion recorded in FY2023.
  • BeOne Medicines' Revenue's 5-year high stood at $3.8 billion during FY2024, with a 5-year trough of $308.9 million in FY2020.
  • Over the past 3 years, BeOne Medicines' median Revenue value was $2.5 billion (recorded in 2023), while the average stood at $2.6 billion.
  • Data for BeOne Medicines' Revenue shows a peak YoY skyrocketed of 280.83% (in 2021) over the last 5 years.
  • Over the past 5 years, BeOne Medicines' Revenue (Yearly) stood at $308.9 million in 2020, then soared by 280.83% to $1.2 billion in 2021, then grew by 20.37% to $1.4 billion in 2022, then soared by 73.65% to $2.5 billion in 2023, then skyrocketed by 54.96% to $3.8 billion in 2024.